Hospital pharmacy

Presentation

The Hospital Pharmacy supports healthcare professionals in the safe use of medicines and medical devices, provides information in line with national, regional and hospital provisions, in support of the safety of care. It prepares customised galenic preparations, especially for paediatric patients. It informs and supports patients in the hospital-territory continuity. Furthermore, it deals with the quality system of radiopharmaceutical preparation best practices in nuclear medicine.
It supports and promotes research.

The hospital pharmacy is structured in specialist areas:

The sector deals with various activities: drug and device monitoring; information and documentation; clinical galenics; reporting and monitoring of expenditure; procurement and logistics.

This sector supports the implementation of all ministerial recommendations supporting the correct and safe use of medicines and medical devices.

The sector supports the Nuclear Medicine Unit with the management of the quality system, as required by the official Italian Pharmacopoeia.

The sector supports independent research and for-profit clinical trials, in the field of technological innovation it participates in HTN evaluation processes.

 

UOC Cardiologia e medicina cardiovascolare - Pisa

Useful numbers

Telephone
0585 493507
Fax
0585 493508
Mail
farmacisti@ftgm.it

Publications

  • Biagini S, La dispensazione dei farmaci ai reparti in regime di day hospital e ai presidi in regime di home care. Ragiufarm, Rassegna Giuridico Farmaceutica, Anno X, n.60, novembre-dicembre 2000: pag. 6-13
  • Volpi E, Giannelli A, Mangione M, Baroni M, Tonazzini S, Alduini S, Biagini S, Laws E. Prevenzione degli errori in terapia durante il ricovero ospedaliero attraverso l’utilizzo della STU elettronica. Boll SIFO 2015;61(3):100-104
  • Volpi E, Giannelli A, Toccafondi G, Tartaglia R, Micalizzi M, Mangione M, Baroni M, Tonazzini S, Alduini S, Biagini S, Laws E and Bellandi T, Human Factors Approach in the Design of an Electronic Medication Management System for Preventing Inpatient Medication Errors. J of Pharmacovigilance 2015, S2:006
  • Volpi E, Giannelli A, Toccafondi G, Baroni M, Tonazzini S, Alduini, S, Biagini S, Gini R, Bellandi T, Emdin M, Medication Reconciliation During Hospitalization and in Hospital-Home Interface: An Observational Retrospective Study. J Patient Saf 2017, Mar 22 [PMID: 28333697]
  • Volpi E, Lo Surdo G, Zizevskikh M, Salvadori S, Toccafondi G, Baroni M, Tonazzini S, Alduini S, Gini R, Bellandi T, Maffei S, Biagini S, Proton-pump inhibitor prescriptions in patients with cardiovascular disease: can the medication reconciliation process and the physician-hospital pharmacist teamwork improve adherence to international and national guidelines? GIFAC 2018;32(3):126-132 | DOI 10.1721/2974.29813
  • Zizevskikh M, Volpi E, Lo Surdo G, Tonazzini S, Alduini S, Da Valle P, Baratta S, Assanta N, Baroni M, Biagini S, Terapia farmacologica alla dimissione nel paziente pediatrico: un percorso condiviso tra ospedale e territorio a garanzia della sicurezza e della continuità delle cure.GIFAC 2019;33(3):112-118
  • Sbrana F, Dal Pino B, Bigazzi F, Ripoli A, Volpi E, Fogliaro MP, Lo Surdo G, Pianelli M, Luciani R, Biagini S, Sampietro T, A large Italian cohort on proprotein convertase subtilisin/kexin type 9 inhibitors. Eur J Prev Cardiol. 2019 Nov 25:2047487319888059. doi: 10.1177/2047487319888059
  • Piccinni C, Antonazzo IC, Maggioni AP, Pedrini A, Calabria S, Ronconi G, Letizia Dondi L, Martini N, Roberto G, Sampietro T, Sbrana F, Dal Pino B, Bigazzi F, Lo Surdo G, Volpi E, Biagini S, Gini R, PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study. Clin Drug Investigation (2019)
  • Aimo A, Cerbai E, Bartolucci G, Adamo L, Barison A, Lo Surdo G, Biagini S, Passino C, Emdin M, Pirfenidone is a Cardioprotective Drug: Mechanisms of Action and Preclinical Evidence, Pharmacological Research, 2020 Feb 12:104694, doi: 10.1016/j.phrs.2020.104694
  • Lo Surdo G, Volpi E, Tonazzini S, Alduini S, Salvadori S, Baroni M, Maffei S, Biagini S, Drug-drug interactions and polypharmacy in patients with cardiovascular diseases: the CARD-REC observational retrospective study. GIFAC 2020;34(3):106-113 | doi 10.1721/3442.34308
  • Genovesi D, Vergaro G, Giorgetti A, Marzullo A, Scipioni M, Santarelli MF, Pucci A, Buda G, Volpi E, Emdin M, [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions. JACC Cardiovasc Imaging 2020 Aug 5;S1936-878X(20)30521-0. doi: 10.1016/j.jcmg.2020.05.031

Staff

Management

Staff

Scrivici tramite il modulo online

Da qui puoi contattare Fondazione Monasterio per informazioni sulle sue attività, per avere un orientamento o cercare specialisti. Puoi scriverci anche per eventuali suggerimenti o feedback sulla tua esperienza con la Fondazione.

    Contatti

    URP – ufficio relazioni pubblico